Say Hello!
Don’t be shy.

   

CRO Tag

XenoGesis has been acquired by leading drug discovery CRO, Sygnature Discovery, strengthening the combined DMPK offering and enhancing existing capabilities and expertise. This latest acquisition by Sygnature serves to meet the increasing demand for DMPK services and boosts the company’s reach into the pre-clinical space. XenoGesis’ novel...

Supporting the discovery and development of new therapeutics during the pandemic Nottingham-based contract research organisations (CROs) have strengthened their existing links to work together and support the discovery and development of new therapeutics during the pandemic. Many businesses have been impacted by the restrictions on the movement...

Excellerate Bioscience is delighted that a close relationship with Omass Therapeutics, built over 18 months, has helped contribute to their success in securing extended series A funding. During this period, Excellerate assembled a dedicated team of expert pharmacologists focussed exclusively on driving forward the Omass...

Platelet specialists Dr Natalia Dovlatova, Ann White and Bob Humphries announce the launch of their new company – ‘Platelet Services Limited’, which will be based in BioCity Nottingham, UK. Collectively, the team has decades of experience in the application of platelet function testing to drug...

X
X
X
X